Indian Drugmaker Stelis Biopharma to Produce 200 Million Doses of Russia's Sputnik V
The developer of Russia's Sputnik V coronavirus vaccine said Friday it had signed a partnership with an India-based drugmaker for the production of 200 million doses of the two-dose jab.
from India News Today: India Live News | Latest India News Online | Current News Headline - News18
Read The Rest:indianexpress...
No comments: